tradingkey.logo

Heartflow Inc

HTFL
View Detailed Chart
27.740USD
+1.750+6.73%
Close 02/06, 16:00ETQuotes delayed by 15 min
2.32BMarket Cap
LossP/E TTM

Heartflow Inc

27.740
+1.750+6.73%
Intraday
1m
30m
1h
D
W
M
D

Today

+6.73%

5 Days

-7.13%

1 Month

-11.00%

6 Months

0.00%

Year to Date

-4.84%

1 Year

0.00%

View Detailed Chart

TradingKey Stock Score of Heartflow Inc

Currency: USD Updated: 2026-02-06

Key Insights

Heartflow Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 129 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 38.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Heartflow Inc's Score

Industry at a Glance

Industry Ranking
129 / 205
Overall Ranking
375 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Heartflow Inc Highlights

StrengthsRisks
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Overvalued
The company’s latest PE is -5.69, at a high 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 1.57M shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
38.500
Target Price
+48.13%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Heartflow Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Heartflow Inc Info

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Ticker SymbolHTFL
CompanyHeartflow Inc
CEOFarquhar (John C. M)
Websitehttps://www.heartflow.com/
KeyAI